Status:

COMPLETED

Evaluation of a New Bladder Health Mobile Application in Pregnancy

Lead Sponsor:

Corewell Health East

Collaborating Sponsors:

University of Pennsylvania

Conditions:

Urinary Incontinence

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

Millions of women experience involuntary loss of urine called urinary incontinence (UI). UI can be slightly bothersome or totally debilitating. Women experience UI twice as often as men. Urinary incon...

Detailed Description

Urinary incontinence (UI) is the involuntary and unintentional leaking of urine. Over 20 million of women experience UI, approximately 34% (range 25-45%) of all US women are affected indicating a sign...

Eligibility Criteria

Inclusion

  • Pregnant women age 18 years or older at 10-18 weeks gestation
  • Ability to understand English
  • Negative history or no more than 5 episodes of UI in the past 12 months
  • Negative history of neuromuscular or genitourinary conditions
  • Low-risk antepartum
  • Singleton pregnancy
  • Owner of a smart phone

Exclusion

  • • High-risk pregnancy, including medical complications during pregnancy, such as preterm delivery, preterm premature rupture of membranes, diabetes, or hypertensive disorders and history of prior diagnosis or treatment (behavioral, drug or surgical) for urinary incontinence

Key Trial Info

Start Date :

April 20 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 15 2024

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT04074044

Start Date

April 20 2023

End Date

August 15 2024

Last Update

September 19 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

William Beaumont Hospitals

Royal Oak, Michigan, United States, 48073